Efficacy of intravenous lipid emulsion as an adjunctive therapy for acutealuminum phosphide poisoning: a randomized, open-label, pilot clinical trial.

Key Points

• Evaluate the effectiveness of intravenous lipid emulsion as an adjunctive treatment for acute aluminum phosphide poisoning.
• Randomized pilot trial design
• Participants received intravenous lipid emulsion in addition to standard care
• Focus on high-risk subgroups
• Significant reduction in mortality rates
• Improvement in metabolic parameters observed in participants receiving the treatment
• Enhancement of outcomes particularly noted in high-risk groups